Latest ResMed News & Updates

See the latest news and media coverage for ResMed. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
ResMed

Medical technology company for sleep and respiratory care

resmed.com
Headquarters
San Diego, United States
Company type
Public company
Number of employees
8,500–10,000

Last updated

Latest news about ResMed

In short: ResMed reported strong Q3 FY2026 growth with an 11% revenue increase and announced the $340 million acquisition of Noctrix Health.

Company announcements

  • ResMed

    ResMed CEO discusses AI and GLP-1 innovations

    Mick Farrell highlights AI for personalized sleep experiences via Smart Comfort and DAWN. GLP-1 therapies boost sleep apnea diagnosis and CPAP engagement for 2.1+ million patients.

  • ResMed

    ResMed announces ENS certification of AirView

    The certification, granted after an independent audit, confirms compliance with strict cybersecurity requirements to protect systems and patient data.

  • ResMed

    ResMed appoints Aaron Bloomer CFO

    Brett Sandercock retires effective May 4, 2026; Bloomer joins from Exact Sciences and Sandercock will advise through 2027.

  • ResMed

    ResMed announces Q3 FY2026 results

    Revenue rises 11% to $1.4B. GAAP EPS hits $2.74; non-GAAP $2.86. Gross margin expands 290 bps. Cash flow reaches $554M.

Unlock all announcements with a

Media coverage

  • The Globe and Mail

    ResMed Announces CFO Transition and Confirms Growth Strategy

    On April 30, 2026, Resmed announced that long-serving Chief Financial Officer Brett Sandercock will retire as CFO on May 4, 2026, after 27 years at...

  • The Globe and Mail

    ResMed Delivers Strong Q3 Results and Margin Expansion

    On April 30, 2026, Resmed reported third-quarter fiscal 2026 results for the period ended March 31, 2026, posting an 11% year-on-year revenue increase to $1.43...

  • Jacobs Management

    ResMed to Acquire Noctrix Health for $340M to Expand into Restless Legs Syndrome

    San Diego, CA, April 30, 2026 (Globe Newswire) -- ResMed (NYSE: RMD) signed a definitive agreement to acquire Noctrix Health for $340 million, adding the...

  • MSN

    ResMed's Q1 earnings call: Our top 5 analyst questions

    ResMed's first quarter saw the company deliver revenue and earnings above Wall Street expectations, yet the market responded negatively. Management attributed the quarter's performance to...

Unlock all articles with a

Never miss news about ResMed

Track ResMed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

ResMed competitors & trending companies

Browse news for competitors to ResMed and other trending companies.